Log in

LON:CTECConvaTec Group Share Price, Forecast & News

GBX 198.10
-0.30 (-0.15 %)
(As of 07/7/2020 02:14 AM ET)
Add
Compare
Today's Range
195.50
Now: GBX 198.10
200.11
50-Day Range
195.60
MA: GBX 204.16
219.20
52-Week Range
142.40
Now: GBX 198.10
225.80
Volume3.80 million shs
Average Volume5.44 million shs
Market Capitalization£3.96 billion
P/E Ratio396.80
Dividend Yield2.26%
BetaN/A
ConvaTec Group Plc develops, manufactures, and markets medical products and technologies worldwide. It offers advanced wound dressings and skin care products for the management of chronic wounds resulting from various conditions, such as diabetes, immobility, and venous disease, as well as for traumatic injury, burns, invasive surgery, and other causes. The company also provides devices, accessories, and services for people with an ostomy or stoma resulting from colorectal cancer, inflammatory bowel disease, bladder cancer, obesity, and other causes. In addition, it offers continence and critical care products, including intermittent urinary catheters; and products for people with urinary continence issues related to spinal cord injuries, multiple sclerosis, spina bifida, and urological disorders, as well as devices and products use in intensive care units and hospital settings. Further, the company provides advanced systems for managing acute fecal incontinence, as well as for monitoring urine production output and intra-abdominal pressure; and various disposable medical devices, such as wound drainage systems, urine collection bags and catheters, airway management and oxygen/aerosol therapy devices, suction handles and tubes, gastroenterology tubes, and securement devices. Additionally, it offers disposable infusion sets to the manufacturers of insulin pumps for diabetes, as well as similar pumps that are used in continuous infusion treatments for other conditions; and various products to hospitals and the home healthcare sector. The company sells its products to pharmacies, hospitals, and other acute and post-acute healthcare service providers directly or through distributors and wholesalers. It serves a range of customers, including healthcare providers, patients, and manufacturers. The company was founded in 2008 and is headquartered in Reading, the United Kingdom.
Read More
ConvaTec Group logo

Beat the Market (BTM) Rank

Analyst Opinion: 2.0Community Rank: 2.4Dividend Strength: 0.8Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.05 out of 5 stars


Industry, Sector and Symbol

Industry Medical Devices
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone44 11 8952 8100

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales£1.83 billion
Cash FlowGBX 19.36 per share
Book ValueGBX 78.90 per share

Profitability

Miscellaneous

Employees9,413
Outstanding Shares2,000,509,952
Market Cap£3.96 billion
Next Earnings Date8/6/2020 (Estimated)
OptionableNot Optionable

Receive CTEC News and Ratings via Email

Sign-up to receive the latest news and ratings for CTEC and its competitors with MarketBeat's FREE daily newsletter.

ConvaTec Group (LON:CTEC) Frequently Asked Questions

How has ConvaTec Group's stock been impacted by COVID-19 (Coronavirus)?

ConvaTec Group's stock was trading at GBX 171.95 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, CTEC shares have increased by 15.2% and is now trading at GBX 198.10. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of ConvaTec Group?

14 Wall Street analysts have issued "buy," "hold," and "sell" ratings for ConvaTec Group in the last year. There are currently 4 sell ratings, 6 hold ratings and 4 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for ConvaTec Group.

When is ConvaTec Group's next earnings date?

ConvaTec Group is scheduled to release its next quarterly earnings announcement on Thursday, August 6th 2020. View our earnings forecast for ConvaTec Group.

How were ConvaTec Group's earnings last quarter?

ConvaTec Group PLC (LON:CTEC) posted its quarterly earnings results on Friday, February, 28th. The company reported $12.00 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $12.70 by $0.70. View ConvaTec Group's earnings history.

How often does ConvaTec Group pay dividends? What is the dividend yield for ConvaTec Group?

ConvaTec Group announced a dividend on Friday, February 28th. Investors of record on Thursday, April 2nd will be given a dividend of GBX 3.09 per share on Thursday, May 14th. This represents a yield of 1.51%. The ex-dividend date of this dividend is Thursday, April 2nd. This is a positive change from ConvaTec Group's previous dividend of GBX 1.40. The official announcement can be accessed at this link. View ConvaTec Group's dividend history.

What price target have analysts set for CTEC?

14 brokerages have issued twelve-month price targets for ConvaTec Group's stock. Their forecasts range from GBX 172 to GBX 280. On average, they anticipate ConvaTec Group's share price to reach GBX 213.45 in the next year. This suggests a possible upside of 7.8% from the stock's current price. View analysts' price targets for ConvaTec Group.

Has ConvaTec Group been receiving favorable news coverage?

Headlines about CTEC stock have trended negative recently, InfoTrie Sentiment Analysis reports. InfoTrie identifies positive and negative news coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. ConvaTec Group earned a media sentiment score of -2.1 on InfoTrie's scale. They also assigned headlines about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an effect on the stock's share price in the immediate future. View the latest news about ConvaTec Group.

Who are some of ConvaTec Group's key competitors?

What other stocks do shareholders of ConvaTec Group own?

Based on aggregate information from My MarketBeat watchlists, some companies that other ConvaTec Group investors own include Enquest (ENQ), Centamin (CEY), Oxford BioMedica (OXB), Bristol-Myers Squibb (BMY), Andalas Energy and Power (ADL), Afren (AFR), CBTX (CBTX), Genel Energy (GENL), Premier Oil (PMO) and Playtech (PTEC).

Who are ConvaTec Group's key executives?

ConvaTec Group's management team includes the following people:
  • Mr. Rick D. Anderson, Interim CEO & Non-Exec. Director (Age 58)
  • Mr. Frank M. Schulkes, CFO & Director (Age 57)
  • Mr. John Crosse, VP of Investor Relations
  • Mr. Adam B. Deutsch, Exec. VP of Corp. Devel. & Gen. Counsel
  • Mr. Douglas Le Fort, Sr. VP of Corp. Devel. (Age 53)

What is ConvaTec Group's stock symbol?

ConvaTec Group trades on the London Stock Exchange (LON) under the ticker symbol "CTEC."

How do I buy shares of ConvaTec Group?

Shares of CTEC and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is ConvaTec Group's stock price today?

One share of CTEC stock can currently be purchased for approximately GBX 198.10.

How big of a company is ConvaTec Group?

ConvaTec Group has a market capitalization of £3.96 billion and generates £1.83 billion in revenue each year. ConvaTec Group employs 9,413 workers across the globe.

What is ConvaTec Group's official website?

The official website for ConvaTec Group is www.convatecgroup.com.

How can I contact ConvaTec Group?

ConvaTec Group's mailing address is 3 Forbury Place Floor 7, 23 Forbury Road, ICKENHAM, RG1 3JH, United Kingdom. The company can be reached via phone at 44 11 8952 8100.

This page was last updated on 7/7/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.